ArticleIDCases2026
BCG gone rogue: A case report of disseminated
Article in IDCases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Introduction: Bacillus Calmette-Guérin (BCG) bladder instillation is an effective therapy for non-muscle-invasive bladder cancer. Disseminated Case presentation: A 59-year-old man presented to the hospital with fevers and chills. His past medical history was significant for renal transplantation with subsequent graft failure. He was maintained on tacrolimus 3 mg twice daily and prednisone 10 mg daily. He also had a history of bladder cancer treated with intravesical BCG immunotherapy 2 years prior to presentation. His hospital course was complicated by persistent undulating fevers. Computed tomography of the chest revealed a small cavitary lesion in the right upper lobe, and positron emission tomography imaging demonstrated increased uptake in the right iliopsoas muscle. A QuantiFERON Gold tuberculosis test was positive. Thirty days after presentation, acid-fast bacillus (AFB) blood cultures obtained at initial presentation, as well as AFB cultures from bronchoalveolar lavage and iliopsoas aspirate, grew pyrazinamide-resistant Conclusion: This case of fever of unknown origin was ultimately attributed to disseminated
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.